Guardant Health AMEA presented four Poster Displays in the annual European Society for Medical Oncology Congress 2019
Home » Guardant Health AMEA presented four Poster Displays in the annual European Society for Medical Oncology Congress 2019

GH AMEA on Social MediaGuardant Health AMEA presented four Poster Displays in the annual European Society for Medical Oncology Congress 2019
Guardant Health AMEA presented four Poster Displays in the annual European Society for Medical Oncology Congress 2019
Guardant Health AMEA presented four Poster Displays in the annual European Society for Medical Oncology Congress 2019
LinkedIn

Guardant Health AMEA will be presenting four Poster Displays in the annual European Society for Medical Oncology Congress, taking place in Barcelona from 27th September to 1st October 2019. Here are the details of the studies which will be presented: Poster Displays – A large scale prospective concordance study of oncogene driver detection between plasma- and tissue-based NGS analysis in advanced non-small cell lung cancer (NSCLC) – Biological difference of tumor mutational burden (TMB) and microsatellite instability (MSI) status in patients with somatic vs germline BRCA1/2-mutated advanced gastrointestinal (GI) cancers using cell-free DNA (cfDNA) sequencing analysis in the GOZILA study – Cell-Free DNA to detect focal versus non-focal MET amplification in metastatic colorectal cancer patients: Combined analysis from Japan and the United States – Combined genomic and epigenomic assessment of cell-free circulating tumor DNA (cfDNA) for cancer diagnosis and recurrence-risk assessment in early-stage lung cancer

Open chat
Message us